| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥25115.2B | ¥23845.2B | +5.3% |
| Operating Income | ¥1724.6B | ¥1967.9B | -12.4% |
| Profit Before Tax | ¥1955.7B | ¥2083.0B | -6.1% |
| Net Income | ¥1502.6B | ¥1528.0B | -1.7% |
| ROE | 9.2% | 9.9% | - |
FY2026 Q3 results show revenue of 25,115.2 billion yen (YoY +5.3%), operating income of 1,724.6 billion yen (YoY -12.4%), and net income of 1,502.6 billion yen (YoY -1.7%). The company achieved top-line growth while facing profitability headwinds. Operating margin contracted to 6.9% from 8.2% in the prior year, reflecting gross margin compression and elevated SG&A expenses. Total assets increased to 35,479.7 billion yen from 33,033.1 billion, while equity strengthened to 16,356.8 billion yen from 15,376.6 billion yen. The full-year guidance projects revenue of 3,300 billion yen with operating income of 210 billion yen and net income of 130 billion yen, representing declines of 8.5% and 7.2% respectively from the prior fiscal year.
Revenue growth of 5.3% to 25,115.2 billion yen demonstrates continued market demand despite challenging conditions. However, this top-line expansion did not translate into profit growth. Gross profit totaled 4,926.7 billion yen with a gross margin of 19.6%, indicating lower-margin product mix or increased input costs. SG&A expenses reached 3,207.6 billion yen, representing 12.8% of revenue, which significantly pressured operating leverage. The operating income decline of 12.4% to 1,724.6 billion yen reflects the dual impact of margin compression and fixed cost deleveraging. Operating margin fell 150 basis points from 8.2% to 6.9%. The gap between operating income (1,724.6 billion yen) and net income (1,502.6 billion yen) was relatively modest at 12.9%, suggesting stable non-operating and tax impacts. Net income decreased only 1.7%, cushioned by comprehensive income contributions totaling 2,382.3 billion yen, which benefited significantly from other comprehensive income. This represents a revenue up/profit down pattern, where volume growth failed to offset profitability pressures from margin deterioration and cost inflation.
[Profitability] ROE of 7.4% was calculated from net profit margin of 4.8%, total asset turnover of 0.708, and financial leverage of 2.17. Operating margin contracted to 6.9% from 8.2% YoY, representing a decline of 130 basis points. Net profit margin of 4.8% reflects the pressure on bottom-line profitability. EBIT margin stood at 6.9% with tax burden ratio of 0.620 and interest burden ratio of 1.134. [Cash Quality] Cash and cash equivalents totaled 4,009.8 billion yen, providing adequate liquidity buffer. Operating cash flow of 1,376.7 billion yen translated to 1.14 times net income, indicating healthy cash-backed earnings. Working capital efficiency shows concern with receivables DSO of 99 days and inventory DIO of 139 days, suggesting collection and turnover challenges. [Investment Efficiency] Total asset turnover of 0.708 reflects moderate asset utilization. Capital expenditure totaled 1,114.2 billion yen, representing aggressive investment activity. Free cash flow generation of 371.0 billion yen after CapEx demonstrates ongoing cash generation capacity. [Financial Health] Equity ratio of 41.0% indicates stable financial foundation. Total liabilities of 19,122.9 billion yen result in debt-to-equity ratio of 1.17. Current assets of 19,787.4 billion yen represent 55.8% of total assets, supporting near-term liquidity. The company maintains a balanced capital structure with moderate leverage.
Operating cash flow of 1,376.7 billion yen represents 1.14 times net income, confirming cash-backed earnings quality and strong conversion from accrual-based profits. This healthy operating CF generation provides foundation for capital allocation activities. Investing cash flow included capital expenditure of 1,114.2 billion yen, reflecting continued investment in productive capacity and future growth platforms. Free cash flow of 371.0 billion yen was generated after CapEx, demonstrating the company's ability to fund investments from operations while retaining cash for shareholder returns. Financing activities included dividend payments of 64.3 billion yen and substantial share buybacks of 50.0 billion yen, totaling 114.3 billion yen in shareholder distributions. The FCF coverage ratio of 0.57 times indicates that free cash flow alone does not fully cover the combined dividend and buyback program, requiring either drawing down cash reserves or supplemental funding. Cash and equivalents position improved to 4,009.8 billion yen, maintaining strong liquidity. The working capital metrics show areas for improvement, with accounts receivable of 6,798.6 billion yen and inventory of 7,689.9 billion yen representing elevated levels relative to the operational cycle, suggesting opportunity for cash release through more efficient working capital management.
Net income of 1,502.6 billion yen versus operating income of 1,724.6 billion yen shows net non-operating impact of approximately 231.1 billion yen flowing through to pre-tax profit of 1,955.7 billion yen. The difference between pre-tax and net income reflects effective tax rate of 38.0%, which includes income taxes and minority interests. Non-operating items comprise interest income, dividend income, equity method investment gains, and foreign exchange impacts, though specific breakdowns are not detailed in the available data. The interest burden ratio of 1.134 indicates net non-operating income added to EBIT rather than detracted from it. Comprehensive income totaled 2,382.3 billion yen, significantly exceeding net income due to other comprehensive income contributions, primarily from valuation gains and foreign currency translation adjustments. Operating cash flow of 1,376.7 billion yen exceeds net income of 1,502.6 billion yen on a nine-month basis, and the OCF-to-NI ratio of 1.14 signals earnings quality is supported by actual cash generation rather than aggressive accruals. However, elevated working capital metrics with DSO of 99 days and DIO of 139 days suggest some earnings are tied up in receivables and inventory, warranting monitoring for potential reversal or write-down risk.
Full-year guidance projects revenue of 3,300 billion yen, operating income of 210 billion yen, and net income of 130 billion yen, representing YoY changes of -8.5% and -7.2% respectively. With Q3 cumulative revenue of 25,115.2 billion yen, the progress rate stands at 76.1% toward the full-year target, which is above the standard 75% benchmark for Q3 and suggests management expects modest Q4 performance. Operating income of 1,724.6 billion yen represents 821.2% of the full-year target of 210 billion yen, indicating the forecast contemplates significant operating income deterioration or non-recurring factors in Q4. This unusual progress rate suggests either conservative Q4 guidance, expected one-time charges, or potential guidance revision needs. Net income progress of 1,502.6 billion yen against 130 billion yen target yields 1,155.8%, far exceeding typical patterns. The guidance implies Q4 operating loss or extraordinary items that would substantially depress profits. Investors should monitor whether management revises guidance upward or clarifies the expected Q4 profit trajectory. The projected dividend of 46 yen per share translates to payout ratio of 24.7% based on forecasted EPS of 186.16 yen, indicating conservative dividend policy relative to earnings guidance.
Annual dividend is projected at 46 yen per share, maintained at the prior year level. Based on net income of 1,502.6 billion yen for the nine-month period, the annualized payout ratio is estimated at approximately 54.2%, positioning dividends at a moderately high level relative to earnings. Share buybacks totaling 50.0 billion yen were executed during the period, representing substantial capital return to shareholders through treasury share acquisitions. The treasury stock balance increased from 23.6 billion yen to 523.5 billion yen, reflecting cumulative buyback activity. Combined dividends and buybacks total approximately 114.3 billion yen, yielding a total return ratio that exceeds free cash flow of 371.0 billion yen on a nine-month basis. The aggressive shareholder return program demonstrates management's commitment to capital distribution, though the FCF coverage ratio of 0.57 indicates the program is supplemented by existing cash reserves. Sustaining this level of total shareholder return requires either improved cash generation through working capital efficiency or moderation of buyback pace in future periods.
Product mix deterioration and gross margin compression of 19.6% present the primary profitability risk, requiring pricing power recovery or cost structure improvement to restore historical margin levels. Elevated working capital with inventory DIO of 139 days and receivables DSO of 99 days creates 50.0 billion yen in potential cash release opportunity but also represents obsolescence and credit risk if turnover does not normalize. The aggressive total shareholder return program of 114.3 billion yen against FCF of 371.0 billion yen creates sustainability pressure, particularly if operating performance does not improve as capex of 1,114.2 billion yen constrains free cash flow generation.
[Industry Position] (Reference - Proprietary Analysis) The company's financial metrics show mixed positioning relative to manufacturing sector medians. Profitability metrics include ROE of 7.4% versus industry median of 5.8%, indicating above-median equity returns despite recent margin pressure. Operating margin of 6.9% compares unfavorably to industry median of 8.9%, suggesting competitive disadvantage or business model differences that compress margins 200 basis points below peers. Net profit margin of 4.8% falls below industry median of 6.5%, reflecting the bottom-line impact of margin compression. Efficiency metrics show asset turnover of 0.708 exceeding industry median of 0.56, demonstrating superior asset utilization that partially offsets margin disadvantage. Working capital metrics reveal receivables DSO of 99 days above industry median of 85 days and inventory DIO of 139 days exceeding median of 112 days, indicating room for improvement in collection and turnover efficiency. Financial health indicators include equity ratio of 41.0% below industry median of 63.8%, reflecting higher financial leverage with debt-to-equity of 1.17. Financial leverage of 2.17 exceeds industry median of 1.53, amplifying ROE through capital structure but increasing financial risk. Revenue growth of 5.3% outpaces industry median of 2.8%, positioning the company in the upper quartile for top-line expansion. The company's historical operating margin progression from 8.2% to 6.9% shows deterioration while industry maintains stable margins, warranting focus on operational efficiency recovery. (Industry: Manufacturing, N=105 companies, Comparison: FY2025 Q3, Source: Proprietary Analysis)
Revenue momentum of 5.3% growth positions the company favorably for market share gains and demonstrates resilient demand, though translation to profit requires margin recovery through pricing discipline or cost optimization. The substantial gap between net income of 1,502.6 billion yen and forecasted full-year 130 billion yen signals either highly conservative guidance or expected material Q4 charges that warrant clarification and monitoring. Working capital efficiency improvement represents immediate cash generation opportunity, with normalization of DSO from 99 to 85 days and DIO from 139 to 112 days potentially releasing billions in operating cash flow to support shareholder returns sustainability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.